• 11/11/2024

China is key market for Singaporean biotech start-up’s stomach cancer early diagnosis kit

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Mainland China will become the largest single market for Mirxes’ core product, a stomach cancer detection kit that was key to the company’s development, according to Zhou Lihan, its CEO and co-founder.

https://www.scmp.com/business/companies/article/3263229/china-key-market-singaporean-biotech-start-ups-stomach-cancer-early-diagnosis-kit?utm_source=rss_feed